US FDA Requires Opioid Class Labeling Changes Despite Adcomm Advice

 
• By Kate Rawson
  
The FDA wants several changes to opioid labels. A few are captured here. (Screenshot of FDA Documents)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Post-Marketing Regulation & Studies

More from United States